MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Sarepta Therapeutics, Inc. (NASDAQ: SRPT)
Finance & Acquisitions: Sarepta
Parents
Sarepta Therapeutics, Inc. (NASDAQ: SRPT)
Children
2016: Is Sarepta Therapeutics About To Shock The Investing World? - Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
2017: Gilead Gets The Best Of Sarepta In $125M PRV Sale - Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
2018: Sarepta all-in on gene therapy pipeline, adding 3 CNS treatments in $30M Lacerta deal – Endpoints News
2024: Sarepta pays $500M cash for rights to 'multiple potential blockbusters' from Arrowhead
Myonexus Therapeutics
Revenue: 301 million USD (2018)
Sarepta Analysts_nasdaq
Sarepta Therapeutics Inc Stock Quote: SRPT Stock News, Quotes, Analysis
www.crunchbase.com
Jumps
*Key People: Sarepta
Organization & Developments: Sarepta